Tissue-engineered vascular grafts created from human induced pluripotent stem cells

Area of Science:

• Biomedical Engineering
• Regenerative Medicine
• Stem Cell Biology

Background:

• Human induced pluripotent stem cells (hiPSCs) offer a promising source for regenerative medicine.
• Developing functional tissue-engineered vascular grafts is crucial for treating cardiovascular diseases.

Purpose of the Study:

• To evaluate the utility of hiPSCs for creating functional tissue-engineered vascular grafts.
• To investigate the impact of chromosomal abnormalities in hiPSC-derived cells on graft development.

Main Methods:

• hiPSCs were differentiated into mesenchymal progenitor cells using a chemically defined, serum-free scheme.
• Mesenchymal progenitor cells were cultured in a pulsatile bioreactor for 8 weeks to engineer vascular grafts.
• Histological and mechanical analyses were performed on the engineered grafts. Karyotyping was used to assess chromosomal stability.

Main Results:

• hiPSC-derived mesenchymal cells expressed key markers and differentiated into multiple lineages.
• Engineered grafts showed smooth muscle cell layers and a collagen-rich matrix, with a burst pressure of 700 mmHg.
• Karyotypically normal clones produced functional grafts, whereas abnormal clones resulted in calcified constructs due to apoptosis.

Conclusions:

• hiPSCs are a viable source for generating tissue-engineered vascular grafts.
• Cellular chromosomal stability is critical for successful graft development and function.
• This approach holds potential for personalized vascular grafts and disease modeling.